Group One Trading
SYRS

Group One Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Group One Trading’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,355
Closed -$771 – 8551
2024
Q4 		$771 Sell
3,355
-4,279
-56% -$5.14K ﹤0.01% 6942
2024
Q3 		$16.4K Buy
7,634
+1,234
+19% +$4.43K ﹤0.01% 5340
2024
Q2 		$33K Buy
+6,400
New +$33.6K ﹤0.01% 4839
2024
Q1 		– Sell
-1,279
Closed -$8.84K – 8133
2023
Q4 		$9.96K Hold
1,279
– – ﹤0.01% 6204
2023
Q3 		$5.05K Hold
1,279
– – ﹤0.01% 6702
2023
Q2 		$4.03K Hold
1,279
– – ﹤0.01% 6811
2023
Q1 		$3.42K Sell
1,279
-97
-7% -$376 ﹤0.01% 6447
2022
Q4 		$4.94K Buy
1,376
+310
+29% +$1.34K ﹤0.01% 6352
2022
Q3 		$7K Buy
+1,066
New +$8.66K ﹤0.01% 6715
2022
Q2 		– Sell
-1,423
Closed -$13.3K – 8679
2022
Q1 		$17K Buy
+1,423
New +$25.5K ﹤0.01% 6884
2021
Q3 		– Sell
-2,335
Closed -$114K – 8914
2021
Q2 		$127K Buy
+2,335
New +$138K ﹤0.01% 5726
2020
Q4 		– Sell
-600
Closed -$54.8K – 7107
2020
Q3 		$53K Buy
600
+580
+2,900% +$65.9K ﹤0.01% 4609
2020
Q2 		$2K Buy
+20
New +$1.79K ﹤0.01% 5590
2020
Q1 		– Sell
-13
Closed -$882 – 5844
2019
Q4 		$1K Buy
13
+10
+333% +$607 ﹤0.01% 5007
2019
Q3 		$0 Hold
3
– – ﹤0.01% 5646
2019
Q2 		$0 Buy
+3
New +$209 ﹤0.01% 5479
2018
Q4 		– Sell
-32
Closed -$2.43K – 5513
2018
Q3 		$4K Sell
32
-292
-90% -$33.9K ﹤0.01% 4920
2018
Q2 		$33K Buy
324
+4
+1% +$495 ﹤0.01% 4173
2018
Q1 		$41K Sell
320
-510
-61% -$55.8K ﹤0.01% 3749
2017
Q4 		$81K Buy
+830
New +$111K ﹤0.01% 3479

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's SYRS Position: Q1 2025 in Review

Group One Trading sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 3,355 shares — an estimated $771 sold.

Group One Trading first reported a position in SYRS in Q4 2017 and held it in 20 quarters. The position peaked at $127K in Q2 2021. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Group One Trading reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 3,355 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $771.
  • Group One Trading first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
  • Group One Trading's Syros Pharmaceuticals, Inc. Common Stock position peaked at $127K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.